Alucent Biomedical Announces $35 Million Series B Financing Led by a Multinational Strategic Investor
Amount Raised
$35 Million
Round Type
Series B
Salt Lake CityBiotechnologyDescription
Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced the close of a $35 million Series B financing round led by a large multinational strategic investor and joined by another new investor, Fresenius Medical Care Ventures. Alucent was founded by the Avera Research Institute, an arm of Avera Health, which also contributed to the financing. Including the Series B funding, the company has raised approximately $60 million to date.
Quick answer
Alucent Biomedical, Inc. raised $35 Million in a Series B round, dated October 1, 2020. Alucent Biomedical, Inc. is based in Salt Lake City, Utah, United States.
- How much did Alucent Biomedical, Inc. raise?
- Alucent Biomedical, Inc. raised $35 Million in a Series B round on October 1, 2020.
- What does Alucent Biomedical, Inc. do?
- Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular..
- Where is Alucent Biomedical, Inc. based and how big is it?
- Alucent Biomedical, Inc. is based in Salt Lake City, Utah, United States.
- Who are the decision-makers at Alucent Biomedical, Inc?
- Fundz holds 1 contact at Alucent Biomedical, Inc., including the Study Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Alucent Biomedical, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Definium Therapeutics raised $248K (Seed) on November 13, 2020.
- Jupiter Biomedical Research, Inc. raised $625K (Seed) on November 13, 2020.
- Edwards Lifesciences raised $114K (Pre-Seed) on November 13, 2020.
- LianBio raised $270M on November 12, 2020.
- ALUNG TECHNOLOGIES INC raised $5.4M on November 12, 2020.
- Decibel Therapeutics, Inc. raised $55M on November 12, 2020.
Who to call at Alucent Biomedical, Inc., and when
A new round usually means Alucent Biomedical, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Alucent Biomedical, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Alucent Biomedical, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Alucent Biomedical, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Alucent Biomedical, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAlucent Biomedical, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.